An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.

Moderna’s new mRNA based seasonal flu vaccine is more effective than traditional flu shots at preventing flu, a late stage ...

A new study will explore the effects of a nasal spray flu vaccine on children's immune systems, aiming to boost future ...

The numbers are in from the first year of required reporting of flu vaccination coverage among nursing home residents, and, ...